Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection

  • Maximillian S. Habibi
  • , Ryan S. Thwaites
  • , Meiping Chang
  • , Agnieszka Jozwik
  • , Allan Paras
  • , Freja Kirsebom
  • , Augusto Varese
  • , Amber Owen
  • , Leah Cuthbertson
  • , Phillip James
  • , Tanushree Tunstall
  • , David Nickle
  • , Trevor T. Hansel
  • , Miriam F. Moffatt
  • , Cecilia Johansson
  • , Christopher Chiu
  • , Peter J. M. Openshaw

Research output: Contribution to journalArticlepeer-review

138 Citations (Scopus)

Abstract

The variable outcome of viral exposure is only partially explained by known factors. We administered respiratory syncytial virus (RSV) to 58 volunteers, of whom 57% became infected. Mucosal neutrophil activation before exposure was highly predictive of symptomatic RSV disease. This was associated with a rapid, presymptomatic decline in mucosal interleukin-17A (IL-17A) and other mediators. Conversely, those who resisted infection showed presymptomatic activation of IL-17– and tumor necrosis factor–related pathways. Vulnerability to infection was not associated with baseline microbiome but was reproduced in mice by preinfection chemokine-driven airway recruitment of neutrophils, which caused enhanced disease mediated by pulmonary CD8 + T cell infiltration. Thus, mucosal neutrophilic inflammation at the time of RSV exposure enhances susceptibility, revealing dynamic, time-dependent local immune responses before symptom onset and explaining the as-yet unpredictable outcomes of pathogen exposure.

Original languageEnglish
Article numbereaba9301
Pages (from-to)eaba9301
JournalScience
Volume370
Issue number6513
DOIs
Publication statusPublished - 9 Oct 2020

Fingerprint

Dive into the research topics of 'Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection'. Together they form a unique fingerprint.

Cite this